Market Overview

Merck Q2 Earnings Preview

Share:

Merck & Co (NYSE: MRK) releases its next round of earnings this Friday. Here's Benzinga's essential guide to Merck's Q2 earnings report.

Earnings and Revenue

Merck EPS will likely be near $1.03 while revenue will be around $10.29 billion, according to analysts.

In the same quarter last year, Merck posted EPS of $1.01 on sales of $9.93 billion. The Wall Street estimate would represent a 1.98 percent increase in the company's earnings. Sales would be up 3.63 percent on a year-over-year basis. Merck & Co's reported EPS has stacked up against analyst estimates in the past like this:

 

Quarter Q1 2018 Q4 2017 Q3 2017 Q2 2017
EPS Estimate 0.99 0.93 1.03 0.87
EPS Actual 1.05 0.98 1.11 1.01

Stock Performance

Over the last 52-week period, shares are up 3.07 percent. Given that these returns are generally positive, long-term shareholders can relax going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement.

Analyst estimates have adjusted higher for EPS and revenues over the past 90 days. The average rating by analysts on Merck stock is a Neutral. The strength of this rating has maintained conviction over the past 90 days.

Posted-In: Earnings News

 

Related Articles (MRK)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Immunogen Earnings Preview

Samsung's 'Unbreakable' Smartphone Screen: What You Need To Know